Welcome!

News Feed Item

Web Tool Highlights Ongoing Impact of Tuberculosis in the United States

Aeras releases TB Crisis Tracker on World TB Day

ROCKVILLE, Md., March 24, 2014 /PRNewswire/ -- The tuberculosis epidemic continues to impact pockets of the U.S. population, according to a data visualization tool developed by the nonprofit biotech, Aeras.  Launched on World TB Day, Aeras's TB Crisis Tracker illustrates how the TB epidemic continues to impact the U.S.

"TB's impact in the U.S. is but a fraction of what it once was, but the Aeras TB Crisis Tracker starkly demonstrates that TB is not a disease of the past, or limited to the poorest countries in the world, but rather one that can strike anywhere, in any population, and at any time," said Kari Stoever, Vice President for External Affairs at Aeras. "This tool provides a powerful reminder that a reported case of TB represents more than just a number on a disease ledger. Each TB case represents a human being, with a name, a face, a story, and a community at risk for exposure."

Often thought to be a disease of the past, TB none-the-less remains a disease of the present, both around the world and in the United States. TB kills 1.3 million people each year, and drug-resistant strains of the disease are making it more difficult and costly to treat. The number of new TB cases occurring in the United States is at an all-time low, but with an increasing proportion of domestic cases occurring among foreign-born residents, the domestic burden of disease is becoming increasingly linked with the global TB epidemic. Until TB is eliminated globally, it will remain a public health threat in the U.S., particularly among at-risk groups, including international travelers, health care workers, first responders and those who work with prisoners and the homeless.

The Tracker highlights a sampling of recent U.S. TB cases occurring in schools, hospitals and other settings that have generated media attention over the past year.  Aeras's goal is to use this tool to raise awareness about the ongoing impact of TB and bring more transparency and attention to reports of TB outbreaks in the U.S. 

The most effective way to stop an epidemic like TB is to prevent its spread. As with every other major infectious disease in the history of mankind, prevention through vaccination can be the most cost-effective tool in eradicating disease burden. Existing TB treatment and control programs are essential to controlling the disease and minimizing its health impact, but innovative new tools like an effective vaccine will be necessary to get ahead of transmission and drive game-changing reductions in disease burden.

"Most people I speak to in the U.S. think they are already vaccinated against TB," notes Ms. Stoever, "but what they believe to be a vaccine is more than likely just the skin test commonly used to check whether a person has been infected with the TB bacteria." The existing TB vaccine – Bacille Calmette–Guerin, or BCG – protects children from some severe forms of TB, but it is unreliable in preventing infectious TB in adolescents and adults – the primary transmitters of the disease – and is not recommended for use in the United States. New, effective TB vaccines would provide the ultimate solution to the epidemic, transforming the effort against this disease by protecting vulnerable populations in the U.S. and around the world from TB's devastating impact.

Scientific progress in TB vaccine R&D is well underway, and investments of more than $600 million over the past decade have produced a robust portfolio of TB vaccine candidates, with more than a dozen candidates currently in clinical trials. Partnerships and collaborations are crucial to advancing the development of these candidates: no one organization or institution can do this alone. Governments, researchers and industry partners from around the world have contributed to the progress that has been made to date, but mobilizing additional partners and resources will be essential to sustaining progress in the field. Expanded contributions from new and existing partners like the U.S. government can help ensure that new TB vaccines are developed as quickly and efficiently as possible.

View the TB Crisis Tracker at www.aeras.org/tbtracker.

About Aeras
Aeras is a nonprofit biotech advancing the development of tuberculosis vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras receives funding from Australian AID, the Bill & Melinda Gates Foundation, the UK Department for International Development, the Netherlands' Ministry of Foreign Affairs, and a range of other governments. Aeras is based in Rockville, Maryland; Cape Town, South Africa; and Beijing, China. www.aeras.org

SOURCE Aeras

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
For financial firms, the cloud is going to increasingly become a crucial part of dealing with customers over the next five years and beyond, particularly with the growing use and acceptance of virtual currencies. There are new data storage paradigms on the horizon that will deliver secure solutions for storing and moving sensitive financial data around the world without touching terrestrial networks. In his session at 20th Cloud Expo, Cliff Beek, President of Cloud Constellation Corporation, ...
SYS-CON Events announced today that Tintri, Inc, a leading provider of enterprise cloud infrastructure, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Tintri offers an enterprise cloud platform built with public cloud-like web services and RESTful APIs. Organizations use Tintri all-flash storage with scale-out and automation as a foundation for their own clouds – to build agile development environments...
In his opening keynote at 20th Cloud Expo, Michael Maximilien, Research Scientist, Architect, and Engineer at IBM, will motivate why realizing the full potential of the cloud and social data requires artificial intelligence. By mixing Cloud Foundry and the rich set of Watson services, IBM's Bluemix is the best cloud operating system for enterprises today, providing rapid development and deployment of applications that can take advantage of the rich catalog of Watson services to help drive insigh...
SYS-CON Events announced today that DivvyCloud will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. DivvyCloud software enables organizations to achieve their cloud computing goals by simplifying and automating security, compliance and cost optimization of public and private cloud infrastructure. Using DivvyCloud, customers can leverage programmatic Bots to identify and remediate common cloud problems in rea...
While some vendors scramble to create and sell you a fancy solution for monitoring your spanking new Amazon Lambdas, hear how you can do it on the cheap using just built-in Java APIs yourself. By exploiting a little-known fact that Lambdas aren’t exactly single threaded, you can effectively identify hot spots in your serverless code. In his session at 20th Cloud Expo, David Martin, Principal Product Owner at CA Technologies, will give a live demonstration and code walkthrough, showing how to ov...
SYS-CON Events announced today that Outscale, a global pure play Infrastructure as a Service provider and strategic partner of Dassault Systèmes, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2010, Outscale simplifies infrastructure complexities and boosts the business agility of its customers. Outscale delivers a secure, reliable and industrial strength solution for its customers, which in...
The 21st International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloudistics delivers a complete public cloud experience with composable on-premises infrastructures to medium and large enterprises. Its software-defined technology natively converges network, storage, compute, virtualization, and management into a ...
Every successful software product evolves from an idea to an enterprise system. Notably, the same way is passed by the product owner's company. In his session at 20th Cloud Expo, Oleg Lola, CEO of MobiDev, will provide a generalized overview of the evolution of a software product, the product owner, the needs that arise at various stages of this process, and the value brought by a software development partner to the product owner as a response to these needs.
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
SYS-CON Events announced today that Tappest will exhibit MooseFS at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. MooseFS is a breakthrough concept in the storage industry. It allows you to secure stored data with either duplication or erasure coding using any server. The newest – 4.0 version of the software enables users to maintain the redundancy level with even 50% less hard drive space required. The software func...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists will examine how DevOps helps to meet th...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software in the hope of capturing value in IoT. Although IoT is relatively new in the market, it has already gone through many promotional terms such as IoE, IoX, SDX, Edge/Fog, Mist Compute, etc. Ultimately, irrespective of the name, it is about deriving value from independent software assets participating in an ecosystem as one comprehensive solution.
SYS-CON Events announced today that EARP will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "We are a software house, so we perfectly understand challenges that other software houses face in their projects. We can augment a team, that will work with the same standards and processes as our partners' internal teams. Our teams will deliver the same quality within the required time and budget just as our partn...